Clinical Trial: Population Pharmacokinetic Modeling and Dosing Optimization of Eravacycline in Critically Ill Patients with Severe Pneumonia (China)

China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Population Pharmacokinetic Modeling and Dosing Optimization of Eravacycline in Critically Ill Patients with Severe Pneumonia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132507

Registration Time: 2026/09/15

Type: Observational study

Primary Sponsor: Tianjin First Central Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341170

Published by HT Digital Content Services with permission from Health Daily Digest....